Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Perforation is the most frequent complication of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) and is associated with adverse events including mortality.

Methods: Among 1,000 consecutive patients enrolled in 12 center prospective CTO PCI study (OPEN CTO), all perforations were reviewed by the angiographic core-lab. Eighty-nine patients (8.9%) with angiographic perforation were compared to 911 patients without perforation. We sought to describe the clinical and angiographic predictors of angiographic perforation during CTO PCI and develop a risk prediction model.

Results: Among eight clinically important candidate variables, independent risk factors for perforation included prior CABG (OR 2.0 [95% CI, 1.2-3.3], p < .01), occlusion length (OR 1.2 per 10 mm increase [95% CI, 1.1-1.3], p < .01), ejection fraction (OR 1.2 per 10% decrease [95% CI, 1.1-1.5], p < .01), age (OR 1.3 per 5 year increase [95%CI, 1.1-1.5], p < .01), and heavy calcification (OR 1.7 [95% CI, 1.0-2.7], p = .04). Three other potential candidate variables, glomerular filtration rate, proximal cap ambiguity, and target vessel, were not independently associated with perforation. The model was internally validated using bootstrapping methods. From the full model, a simplified perforation prediction score (OPEN-CLEAN score: CABG, Length [occlusion], EF < 50%, Age, CalcificatioN) was developed, which discriminated the risk of angiographic perforation well (c-statistics = 0.75) and demonstrated good calibration.

Conclusion: This simple 5-variable prediction score may help CTO operators to risk-stratify patients for angiographic perforation using variables available prior to CTO PCI procedures.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29466DOI Listing

Publication Analysis

Top Keywords

angiographic perforation
12
chronic total
8
total occlusion
8
percutaneous coronary
8
coronary intervention
8
cto pci
8
perforation
7
angiographic
5
development validation
4
validation prediction
4

Similar Publications

Objective: Lenticulostriate artery (LSA) reperfusion is critical for basal ganglia blood supply. Basal ganglia infarction (BGI) inconveniencing patients with large artery occlusion and occluded perforators may influence clinical outcomes. This study aims to investigate the association between LSA recanalization, BGI, and long-term outcome after thrombectomy in the ischemic hemisphere.

View Article and Find Full Text PDF

Basilar Artery Perforator Aneurysms: A Single-Center Experience with Conservative Management.

J Neuroendovasc Ther

July 2025

Department of Diagnostic and Interventional Neuroradiology, Instituto de Neurocirugía Dr. Alfonso Asenjo, Santiago, Chile.

Objective: Basilar artery perforating aneurysms (BAPAs) represent an infrequent clinical finding, typically manifesting as subarachnoid hemorrhage (SAH). Consensus on the optimal management of this rare entity is lacking. We report a single-center case series of 11 patients diagnosed with BAPAs, providing a detailed description of their clinical presentation, management course, and follow-up.

View Article and Find Full Text PDF

Background: The aim of this study was to assess the safety and effectiveness of abciximab (ReoPro®), a glycoprotein-IIb/IIIa receptor antagonist, in the management of thromboembolic complications during endovascular treatment of intracranial aneurysms.

Methods: From an inhouse data base of 218 coil embolisations in 178 patients with cerebral aneurysms (median age 57 years, 72% females)-among them 53 interventions with subarachnoid hemorrhage (SAH) requiring acute endovascular treatment, and 165 with elective endovascular treatment of unruptured aneurysms - we retrospectively reviewed 53 interventions that received abciximab during endovascular treatment, and diffusion-weighted imaging after endovascular treatment (median 7 days after intervention, range 5 to 9 days). Four subgroups were identified, (i) SAH patients with abciximab (SAH-Ab,  = 18), (ii) SAH patients without abciximab (SAH-no,  = 35), (iii) elective patients with abciximab (El-Ab,  = 31), and (iv) elective patients without abciximab (El-no,  = 134) treatment.

View Article and Find Full Text PDF

Outcomes Following Orbital Atherectomy for Coronary Calcified Nodules: A Retrospective Single-Center Experience.

Catheter Cardiovasc Interv

September 2025

Department of Medicine, Division of Cardiology, School of Medicine, University of Louisville, Louisville, Kentucky, USA.

Background: Coronary calcified nodules (CNs) are a challenging subset of calcific lesions associated with adverse procedural outcomes. While rotational atherectomy (RA) and balloon angioplasty (BA) have been traditionally used, orbital atherectomy (OA) offers a unique mechanism of plaque modification that may be advantageous in the treatment of CNs. Data on OA in CNs remains limited.

View Article and Find Full Text PDF

Background: The impact of target vessel diameter on outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) has received limited study.

Aim: To compare the impact of target vessel diameter on CTO PCI outcomes.

Methods: We examined the association of vessel diameter with clinical, angiographic characteristics, and procedural outcomes of CTO-PCI in a large multicenter registry.

View Article and Find Full Text PDF